Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1. (Q38835384)

6 September 2017

title

Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1. (English)

1 reference

6 September 2017

Bhakti R Pathak

1 reference

6 September 2017

Ananya A Breed

1 reference

6 September 2017

Snehal Apte

1 reference

6 September 2017

Kshitish Acharya

1 reference

6 September 2017

Smita D Mahale

1 reference

6 September 2017

publication date

14 September 2015

1 reference

Molecular and Cellular Biochemistry

6 September 2017

published in

1 reference

6 September 2017

volume

411

1 reference

6 September 2017

issue

1-2

1 reference

6 September 2017

page(s)

11-21

1 reference

Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients' prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

The CAP superfamily: cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins--roles in reproduction, cancer, and immune defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

The human cysteine-rich secretory protein (CRISP) family. Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

SGP28, a novel matrix glycoprotein in specific granules of human neutrophils with similarity to a human testis-specific gene product and a rodent sperm-coating glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Cysteine-rich secretory protein 3 inhibits hepatitis C virus at the initial phase of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Pseudechetoxin binds to the pore turret of cyclic nucleotide-gated ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

The cysteine-rich secretory protein domain of Tpx-1 is related to ion channel toxins and regulates ryanodine receptor Ca2+ signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

beta-Microseminoprotein binds CRISP-3 in human seminal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Biology of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Predicting the risk of bone metastasis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Annexin 1: the new face of an old molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Annexin A1 attenuates EMT and metastatic potential in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2564-2

Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence

21 January 2018

1 reference

12 December 2020

Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis

1 reference

12 December 2020

Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone

1 reference

12 December 2020

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

12 December 2020

Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia

1 reference

12 December 2020

Selective secretion of annexin 1, a protein without a signal sequence, by the human prostate gland

1 reference

12 December 2020

Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer

1 reference

12 December 2020

Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion

1 reference

12 December 2020

Prostate-specific antigen: any successor in sight?

1 reference

12 December 2020

Androgen receptor gene amplification increases tissue PSA protein expression in hormone-refractory prostate carcinoma

1 reference

12 December 2020

A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis

1 reference

12 December 2020

Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden

1 reference

12 December 2020

10.1007/S11010-015-2564-2

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1035099236

0 references

1 reference